US2014271831A1PendingUtilityA1

Racecadotril liquid compositions

Assignee: MCNEIL PPC INCPriority: Mar 15, 2013Filed: Mar 12, 2014Published: Sep 18, 2014
Est. expiryMar 15, 2033(~6.6 yrs left)· nominal 20-yr term from priority
Inventors:Der-Yang Lee
A61P 43/00A61K 9/4858A61K 9/205A61K 9/0095A61K 9/08A61K 31/265A61K 31/451A61K 31/724A61K 47/40A61K 31/695A61K 31/197A61K 31/223A61P 1/12A61K 2300/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A liquid composition comprising racecadotril and cyclodextrin.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A liquid composition comprising racecadotril and cyclodextrin, wherein the cyclodextrin is a sulfobutyl ether derivative of β-cyclodextrin. 
     
     
         2 . The composition of  claim 1 , wherein the racecadotril is an RS racemic form or R form. 
     
     
         3 . The composition of  claim 1 , wherein the racecadotril is present in an amount of from about 0.10 grams to about 0.30 grams per 100 ml of the liquid composition 
     
     
         4 . (canceled) 
     
     
         5 . The composition of  claim 1 , wherein the cyclodextrin is present in an amount of from about 6 grams to about 8 grams per 100 ml of the liquid composition. 
     
     
         6 . The composition of  claim 1 , further comprising an optional ingredient selected from the group consisting of buffers, preservatives, sweeteners, viscosity modifiers, colors, aromas, flavors, and mixtures thereof. 
     
     
         7 . The composition of  claim 6 , wherein the buffer is a citrate, an acetate, a phosphate, or mixtures thereof. 
     
     
         8 . The composition of  claim 6 , wherein the sweetener is sorbitol, high fructose corn syrup, sucralose, aspartame, saccharine, sucrose, or mixtures thereof. 
     
     
         9 . The composition of  claim 6 , wherein the preservative is sodium benzoate, potassium benzoate, propyl paraben, methyl paraben, butyl paraben, or mixtures thereof. 
     
     
         10 . A liquid composition comprising:
 about 0.1 wt. % to about 0.3 wt. % racecadotril;   about 6 wt. % to about 8 wt. % cyclodextrin, wherein the cyclodextrin is a sulfobutyl ether derivative of β-cyclodextrin;   about 16 wt. % to about 19 wt. % sorbitol;   about 45 wt. % to about 55 wt. % high fructose corn syrup;   about 0.1 wt. % to about 0.4 wt. % sodium chloride;   about 0.1 wt. % to about 0.8 wt. % polyethylene glycol;   about 15 wt. % to about 30 wt. % water; and   about 0 wt. % to about 0.5 wt. % flavor,   wherein each wt. % is based upon 100 ml of the composition.   
     
     
         11 . The liquid composition of  claim 1  comprising racecadotril, wherein the liquid composition has a pH of from about 3 to about 5 at 25° C. 
     
     
         12 . A soft shell solid dosage form comprising the composition of  claim 1 . 
     
     
         13 . A hard shell solid dosage form comprising the composition of  claim 1 . 
     
     
         14 . The composition of  claim 1 , wherein the composition is delivered orally. 
     
     
         15 . The composition of  claim 1 , wherein the composition is a liquid oral dosage form. 
     
     
         16 . A tablet dosage form comprising the composition of  claim 1 . 
     
     
         17 . A method for treating a subject experiencing diarrhea comprising the step of orally administering to the subject a composition comprising racecadotril and cyclodextrin, wherein the cyclodextrin is a sulfobutyl ether derivative of β-cyclodextrin.

Join the waitlist — get patent alerts

Track US2014271831A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.